Covid-19 vaccines are poised to become big business. Its potential to generate staggering revenue has already added billions of dollars to the market value of drug makers like Pfizer and Moderna.. That promise is also drawing scrutiny in Washington. Rising prescription drug costs are one of the few problems where …
Read More »
Text size Peter Foley / Bloomberg Bigger banks have reported profits, and investors can be forgiven if they are unsure where the opportunities are now. The answer may lie in how much uncertainty they are willing to accept. Analysts warned that the quarter would be “sloppy” and “confusing,” and banks …
Read More »
If Tesla is added to the S&P 500 stock index this year, it will be a great victory for the electric vehicle maker and its shareholders. This is because money managers who manage funds that track the index or compare its performance against it will have to buy Tesla shares. …
Read More »
As the Covid-19 crisis intensifies in the United States, the fight for an effective vaccine is about to collide with the electoral calendar. Pfizer (ticker: PFE) says it will seek authorization from the Food and Drug Administration for its Covid-19 vaccine starting in October. Meanwhile, the federal government’s Covid-19 vaccine …
Read More »
Europe has increased the stimulus, with countries like France launching larger-than-expected packages to boost the economy. Philippe Lopez / Getty Images Text size While the state of the Covid-19 pandemic in the US and China has been largely focused, Europe has quietly progressed. Policy makers have come together and worked …
Read More »